| Media, News, Press Release

【Successful Development of Pathological AI】Now Possible to Classify Prostate Cancer in Histopathological Whole Slide Images -Published in Diagnostics-

Medmain Inc., a provider of the digital pathology support solutions “PidPort”, has successfully developed a pathological AI that enables to classify prostate cancer with extremely high accuracy in needle biopsy whole slide images using transfer learning.

We are also pleased to announce that a paper on this development has been posted on Diagnostics, issued by MDPI (, and was published in a special issue of Artificial Intelligence in Pathological Image Analysis on March 21, 2022.